Expression levels for many genes in human peripheral blood cells are highly sensitive to ex vivo incubation
- 3 June 2004
- journal article
- research article
- Published by Springer Nature in Genes & Immunity
- Vol. 5 (5) , 347-353
- https://doi.org/10.1038/sj.gene.6364098
Abstract
Monitoring of gene and protein expression in peripheral blood cells has significant potential for improving the diagnosis and therapy of many human diseases. As genomic-scale microarray and proteomic technologies are applied to peripheral blood, it is important to consider the variables that may affect interpretation of data. Here we report experiments performed to identify genes that are particularly sensitive to ex vivo handling prior to RNA extraction for gene expression microarrays or quantitative real-time RT-PCR assays. We examined Affymetrix gene expression in samples from eight normal individuals where blood was processed for RNA either immediately after blood draw or the next day following overnight incubation. These studies identified hundreds of genes that are sensitive to ex vivo handling of blood, and suggest that this is an important variable to consider when designing and interpreting human PBMC experiments.Keywords
This publication has 23 references indexed in Scilit:
- Ratchets and clocks: the cell cycle, ubiquitylation and protein turnoverNature Reviews Molecular Cell Biology, 2003
- Fine mapping the phenotype in autoimmune disease: the promise and pitfalls of DNA microarray technologiesGenes & Immunity, 2003
- Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus BloodThe Journal of Experimental Medicine, 2003
- Expression of Cytokine- and Chemokine-Related Genes in Peripheral Blood Mononuclear Cells from Lupus Patients by cDNA ArrayClinical Immunology, 2002
- Gene Expression Profiling of Lymphoid MalignanciesAnnual Review of Medicine, 2002
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences, 2001
- Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease.Journal of Clinical Investigation, 1996
- Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosisNature, 1992
- Rheumatoid ArthritisNew England Journal of Medicine, 1990
- B cell and T cell lymphopenia in systemic lupus erythematosusCellular Immunology, 1974